Skip to main content

UBS Group AG

Position in CNTA — Centessa Pharmaceuticals plc

CIK 1610520 ZURICH, V8

Position in CNTA

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$0
+$0 QoQ
Shares Held
359,939
-33.0% QoQ
Ownership
0.233%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2021
18 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in CNTA Over Time

Shares Held

Position Value (USD)

Derivatives in CNTA

reported options exposure · as of Dec 31, 2025
CallValue
$0
CallShares
35,300
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in CNTA

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-03-31 359,939
2025-12-31 537,518
2025-12-31 35,300
2025-09-30 85,178
2025-09-30 45,300
2025-06-30 209,750
2025-06-30 45,300
2025-03-31 73,483
2024-12-31 1,070,209
2024-09-30 5,007
2024-06-30 2,809
2024-03-31 1,878
2023-12-31 1,583
2023-09-30 2,636
2023-06-30 2,118
2023-03-31 5,163
2022-12-31 2,586
2022-09-30 1,558
2021-12-31 496
2021-09-30 221
2021-06-30 678